Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study

Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017

(2020) Maria Gańczak et al.   PLoS One

30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 – 2016/17

(2020) Renata Cífková et al.   PLoS One

Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries

(2020) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

Statins and PCSK9 inhibitors: A new lipid-lowering therapy

(2020) Enrique Gallego-Colon et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic

(2020) Zdeněk Chmelík et al.   Central European Journal of Public Health

Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go

(2020) Maciej Banach et al.   JAMA Network Open

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

(2019) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study

(2019) Ivo Petrov et al.   ADVANCES IN THERAPY

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

(2019) Guy De Backer et al.   ATHEROSCLEROSIS

National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries

(2019) et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study

(2018) Jean Ferrières et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey

(2018) Delphine De Smedt et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)

(2018) Nicolas Danchin et al.   European Journal of Preventive Cardiology

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Gregory A Roth et al.   LANCET

Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia

(2018) Hye Duck Choi et al.   MEDICINE

Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients

(2018) Krzysztof Dyrbus et al.   PHARMACOLOGICAL RESEARCH

Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL–C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study

(2017) Rongjing Ding et al.   Journal of Global Health

Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey

(2016) Ž. Reiner et al.   ATHEROSCLEROSIS

Cardiovascular disease in Europe: epidemiological update 2016

(2016) Nick Townsend et al.   EUROPEAN HEART JOURNAL

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries

(2016) Min Zhao et al.   European Journal of Preventive Cardiology

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: Findings from the EUROASPIRE III survey

(2013) Željko Reiner et al.   ATHEROSCLEROSIS

An International Model to Predict Recurrent Cardiovascular Disease

(2012) Peter W.F. Wilson et al.   AMERICAN JOURNAL OF MEDICINE

Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study

(2011) Tomasz Tomasik et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey

(2010) Željko Reiner et al.   ATHEROSCLEROSIS